Current Funding Opportunities FEATURES Duration: Up to 2+4 years Support : Up to $275K for 2 yrs + Up to $1.5M for 4 years; no > 5 yrs Renew : No Pages : 12 pages PO: Sarah Duffy AIDS-Science Track Award for Research Transition – A-START (R03; PA-10-021) Expires: September 8, 2012 FEATURES Duration: 2 years Support : $100K per yr Renew: No Pages : 6 pages PO: Richard Jenkins Phased Services Research Studies of Drug Use Prevention, Addiction Treatment, and HIV in an Era of Health Care Reform (R21/R33; RFA-DA-13-001) Expires: August 23, 2012
Current Funding Opportunities Accelerating Pace of Drug Abuse Research Using Existing Epidemiology, Prevention & Treatment (R01; PAR-10-018) Expires January 8, 2013 FEATURES Duration - 3 years Support : Up to $450K Renew : Yes; Pages: 12 $2M to fund 5-8 grants PO: Marsha Lopez Drug Abuse Prevention Intervention Research (R01, R21, R03; PA-11-311- 313) Expires: September 8, 2014 FEATURES: R01 R03 R21 Duration : 5 yrs 2 yrs 2 yrs Support:...$ $100K $275 Renew: Yes No No Pages: 12 6 6 POC: Harold Perl
Current Funding Opportunities FEATURES Duration - 3 years Support : Up to $450K Renew: No Pages : 12 PO: Jacqueline Lloyd (NIDA) Judith Arroyo (NIAAA) FEATURES: Duration : 3 years Support: Up to $450K Renew: No Pages: 12 Po: Rich Jenkins, Shoshana Kahana, Will Aklin Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation (R34; PA-12-231) Expires: May 8, 2015 Pilot and Feasibility Studies in Preparation for Drug Abuse Prevention Trials (R34; PA-12-171) Expires: May 8, 2015
Current Funding Opportunities FEATURES: R01 R34 Duration : 5 yrs 3 yrs Support: avail of $ $450K Renew: Yes No Pages: 12 12 PO: Shoshana Kahana, Will Aklin FEATURES: R01 R03 R21 Duration : 5 yrs 2 yrs 2 yrs Support:...$ $100K $275 Renew: Yes No No Pages: 12 6 6 PO: Rich Jenkins, Dionne Jones, Will Alkin Drug Abuse Aspects of HIV/AIDS (R03, R21, R01; PA-10-129- 130) Expires: January 8, 2012 Technology-Based Interventions to Promote Engagement in Care and Treatment Adherence for Substance Abusing Populations with HIV (R01; R34; PA-12-117-118) Expires: January 8, 2015
Current Funding Opportunities FEATURES Duration - 3 years Support : Up to $450K Renew : No Pages : 12 PO: Lori Ducharme (NIDA); Robert Huebner (NIAAA) Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse (R34; PA-12-130) Expires: May 8, 2015 Behavioral and Integrative Treatment Development Program (R01, R03, R34; PA-10-012- 013) Expires: January 8, 2013 FEATURES: R01 R03 R34 Duration : 5 yrs 2 yrs 3 yrs Support:...$ $100K $450 Renew: Yes No No Pages: 12 6 12 PO: Lisa Onken, Daniel Falk, Jeanette Hosseini
NIH Parent Announcements R01 – Research Project Grant (Parent R01) - PA-11-260PA-11-260 R23 - NIH Exploratory/Developmental Research Grant Program (Parent R21) - PA-11-261PA-11-261 R03 - NIH Small Research Grant Program (Parent R03) - PA-11-262 PA-11-262
Suggestions/Strategies Become familiar with Funding Opportunity Announcements – http://ww1.drugabuse.gov/funding/pa http://ww1.drugabuse.gov/funding/pa Identify appropriate/relevant Institutes. Develop a relationship with Project Officer in relevant Institute/Division. Get Program Officer feedback on concept paper. Communicate with Program Officer during concept/application development, prior to submission, after review. Become familiar with review committees. Develop/maintain relationships with strong mentors and collaborators.
Submit a Concept Paper Study Goals You want support to do what? Problem/Significance Why does this topic need study? Research Question What hypotheses will you test? Design/Analysis What study design and statistical approach do you propose? Team Who will be the key participants and collaborators? A concept paper describes your research plans concisely. It’s a tool to facilitate productive discussion with an NIH Program Official. Suggest 1 page.
Good Luck!!! Jacqueline Lloyd National Institute on Drug Abuse Division of Epidemiology, Services and Prevention Research Prevention Research Branch email@example.com